FDA inspection
Suzhou Union Biopharm Co., Ltd.: FDA inspection ending May 26, 2023
FDA inspection 1209449 · Voluntary Action Indicated (VAI) · Suzhou
Key facts
| Inspection ID | 1209449 |
|---|---|
| Firm | Suzhou Union Biopharm Co., Ltd. |
| FEI number | 3014164694 |
| Address | Wujiang Economic And Technological Development, 999 Longqiao Road; Songlingzhen Wujiang |
| City | Suzhou |
| Fiscal year | 2023 |
| Inspection end date | May 26, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data